Clinical Trials in San Diego

Showing 2741-2760 of 12,589 trials

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

NCT01766297

The purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will prove to be beneficial for women with early stage breast cancer. A clinical study is necessary to compare the results (good or bad) of proton radiation therapy.

Breast CancerBreast NeoplasmBreast Tumor+1 more

Proton Collaborative Group132 participantsStarted Feb 2013

Scottsdale, Arizona, United States • San Diego, California, United States • Warrenville, Illinois, United States +6 more locations

Active Not RecruitingNA< 1 mile

Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury

NCT03655782

The proposed study tests the efficacy (Phase II) of 36 30-minute training sessions of PATH neurotraining followed by digit memory exercises to improve working memory, processing speed and attention in mTBI patients rapidly and effectively to provide clinical testing of a therapeutic training for the remediation of cognitive disorders caused by a concussion. This study will contribute to the fundamental knowledge of how to remediate concussions from a mTBI to enhance the health, lengthen the life and reduce the disabilities that result from a mTBI.

MTBI - Mild Traumatic Brain Injury

Perception Dynamics Institute90 participantsStarted Jul 2023

San Diego, California, United States • Solana Beach, California, United States

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury

Find Trials by Condition in San Diego

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

OCS DCD Heart + CAP Continued Follow-Up

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Phase 2b Study of ALTO-100 in MDD

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

FebriDx® Method Comparison Study Protocol

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

A Study of LM-24C5 For Advanced Solid Tumors

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Skin Reactions Related to Thoracic Implantable Chamber Dressings